Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS‐FANTASIO study)-Reference-Cited by-同舟云学术

Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS‐FANTASIO study)

Published:2019-11-20 Issue:3 Volume:115 Page:573-582
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Barré Tangui¹²^ORCID,Marcellin Fabienne¹²,Di Beo Vincent¹²,Delorme Jessica³,Rojas Rojas Teresa¹²,Mathurin Philippe⁴,Protopopescu Camelia¹²,Bailly François⁵,Coste Marion¹²,Authier Nicolas³,Carrieri Maria Patrizia¹²^ORCID,Rolland Benjamin⁶^ORCID

Affiliation:

1. Aix Marseille Université, INSERM, IRD, SESSTIM, Sciences Economiques and Sociales de la Santé and Traitement de l'Information Médicale Marseille France

2. ORS PACA, Observatoire Régional de la Santé Provence‐Alpes‐Côte d'Azur Marseille France

3. CHU Clermont‐Ferrand, Neuro‐Dol, Service de pharmacologie médicale, Centres addictovigilance et pharmacovigilanceUniversité Clermont Auvergne Clermont‐Ferrand France

4. Service des maladies de l'appareil digestif, CHU LilleUniversité de Lille Lille France

5. Service d'hépatologie et d'addictologie, Groupe hospitalier Nord, Hôpital de la Croix‐Rousse Lyon France

6. Service Universitaire d'Addictologie de Lyon (SUAL), CH Le VinatierUniversité de Lyon Bron France

Funder

Agence Nationale de Recherches sur le Sida et les Hépatites Virales

Merck Sharp and Dohme

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/add.14820

Reference68 articles.

1. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013

2. Mortality rates in patients with chronic hepatitis C and cirrhosis compared with the general population: a Danish cohort study;Hallager S.;J Infect Dis,2017

3. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

4. European Monitoring Centre for Drugs and Drug Addiction.Hepatitis C among drug users in Europe: epidemiology treatment and prevention [internet].2016. Available at:http://www.emcdda.europa.eu/publications/insights/hepatitis‐c‐among‐drug‐users‐in‐europe_en(accessed 29 August 2018).

5. Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hazardous Alcohol Use and Its Effect on Direct-Acting Antiviral Therapy Initiation among People with Active Injection Drug Use and Current Hepatitis C Infection;Viruses;2024-09-05

2. Food inequity and insecurity and MASLD: burden, challenges, and interventions;Nature Reviews Gastroenterology & Hepatology;2024-07-29

3. Real‐world economic burden of hepatitis C and impact of direct‐acting antivirals in France: A nationwide claims data analysis;Liver International;2024-02-20

4. Biomarkers of Innate Immunity and Immunological Susceptibility to Viral Infection in Patients with Alcoholic Cirrhosis;Biomedicines;2024-02-01

5. Hepatitis C virus cure from direct‐acting antivirals and mortality: Are people with and without a history of injection drug use in the same boat? (ANRS CO22 Hepather cohort);Drug and Alcohol Review;2023-12-22